Want to join the conversation?
The Dublin, Ohio-based prescription drug distributor $CAH said that in generics, the company continues to grow its base of customers spanning independent pharmacies, chain, institutional and hospital pharmacies. The company saw a steep growth in its specialty solutions business in 2Q16 and expects its sales to exceed $8Bil in FY16.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.